Unknown Manufacturer
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Beraprost acts by binding to prostacyclin membrane receptors ultimately inhibiting the release of Ca from intracellular storage sites. This reduction in the influx of Ca has been postulated to cause relaxation of the smooth muscle cells and vasodilation.
For the treatment of pulmonary hypertension.
4 associated conditions
